Swine influenza
MONDO:0005460An acute viral respiratory infection caused by a strain of influenza virus which is endemic in swine (pigs). Rarely reported in humans prior to 2009, the disease is caused by a mutated strain of swine influenza A (H1N1) virus. It is highly contagious and spreads mainly through coughing and sneezing. Signs and symptoms include fever, chills, coughing, sore throat headache, muscle ache, and generalized weakness. Antiviral medications are most effective in the first two days of the illness.
Also known as: H1N1 Influenza, H1N1 Virus infection, H1N1 flu, Influenza A (H1N1), Influenza A (H1N1) Virus infection, Swine influenza virus caused influenza, Swine influenza virus influenza, swine flu
93 clinical trials for this condition and its sub-types, 35 tagged with Swine influenza itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
AstraZeneca launches human tests for bird flu vaccines
Vaccine OngoingThis study tests two experimental vaccines, AZD4117 and AZD5315, designed to protect against certain strains of avian influenza (bird flu), specifically H5N1 and H7N9. Around 405 healthy adults will receive either a vaccine or a placebo to see if the vaccines are safe and trigger…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Vaccine
Last updated Jul 22, 2026 00:00 UTC
-
New flu pill TRX-100 tested for safety and symptom relief
Symptom relief OngoingThis early-stage study tests different doses of an experimental flu medicine called TRX-100, taken alongside standard care, in 105 people with mild to moderate influenza. The main goals are to check safety and find the best dose. Researchers will also track how well it eases flu …
Phase 2 • Sponsor: Traws Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New flu pill for kids shows promise in early trial
Symptom relief OngoingThis study tests a new medicine called ZSP1273 in children aged 2 to 11 who have influenza A. The goal is to see if it can shorten flu symptoms and is safe. About 119 children in China will take either ZSP1273 or the standard flu drug oseltamivir.
Phase 3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New flu pill shows promise for teens in Late-Stage trial
Symptom relief OngoingThis phase 3 trial tests whether the experimental drug ZSP1273 can shorten flu symptoms in teenagers aged 12-17 with uncomplicated influenza A. About 157 participants in China will receive either the drug or a placebo. The main goal is to see how quickly symptoms like cough, feve…
Phase 3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Experimental device trial: what you need to know
Knowledge-focused Details not publishedThis trial is studying a device that has not been approved by the U.S. FDA. The purpose is to gather information about how the device works and its safety. Participants will be monitored closely. The study sponsor and current status are not publicly available.
Sponsor: [Redacted] • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC